These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36989573)

  • 1. Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma.
    Tornín J; Mateu-Sanz M; Rey V; Murillo D; Huergo C; Gallego B; Rodríguez A; Rodríguez R; Canal C
    Redox Biol; 2023 Jun; 62():102685. PubMed ID: 36989573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
    Wang X; Goldstein D; Crowe PJ; Yang JL
    Anticancer Res; 2014 Nov; 34(11):6537-45. PubMed ID: 25368256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
    IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-Dependent Effects of Cold Atmospheric Argon Plasma on the Mesenchymal Stem and Osteosarcoma Cells In Vitro.
    Ermakov AM; Ermakova ON; Afanasyeva VA; Popov AL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
    Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
    Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties.
    Tornín J; Villasante A; Solé-Martí X; Ginebra MP; Canal C
    Free Radic Biol Med; 2021 Feb; 164():107-118. PubMed ID: 33401009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
    Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
    Ji XL; He M
    Aging (Albany NY); 2019 Aug; 11(15):5848-5863. PubMed ID: 31422383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
    Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma.
    Tornin J; Mateu-Sanz M; Rodríguez A; Labay C; Rodríguez R; Canal C
    Sci Rep; 2019 Jul; 9(1):10681. PubMed ID: 31337843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Cold Atmospheric Plasma Devices' Efficacy on Osteosarcoma and Fibroblastic
    Gümbel D; Suchy B; Wien L; Gelbrich N; Napp M; Kramer A; Ekkernkamp A; Daeschlein G; Stope MB
    Anticancer Res; 2017 Oct; 37(10):5407-5414. PubMed ID: 28982850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
    Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
    Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.